Condition Strategy

Cellular Senescence Burden

Lower inflammatory load linked to senescent cell accumulation

Evidence Level C

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Guidance Summary

Human senolytic evidence is still early and condition-specific, so protocols should stay conservative, prioritize functional monitoring, and avoid extrapolating animal-effect sizes to broad anti-aging claims.

Top Interventions

  • resistance training
  • anti-inflammatory nutrition
  • protocolized senolytic cycles

Monitoring Priorities

  • hs-CRP
  • functional strength metrics
  • recovery markers
  • bone health trends

Source Links